×
The submission system is temporarily under maintenance. Please send your manuscripts to
Go to Editorial ManagerLung cancer is the most common dangerous disease that, if treated late, can lead to death. It is more likely to be treated if successfully discovered at an early stage before it worsens. Distinguishing the size, shape, and location of lymphatic nodes can identify the spread of the disease around these nodes. Thus, identifying lung cancer at the early stage is remarkably helpful for doctors. Lung cancer can be diagnosed successfully by expert doctors; however, their limited experience may lead to misdiagnosis and cause medical issues in patients. In the line of computer-assisted systems, many methods and strategies can be used to predict the cancer malignancy level that plays a significant role to provide precise abnormality detection. In this paper, the use of modern learning machine-based approaches was explored. More than 70 state-of-the-art articles (from 2019 to 2024) were extensively explored to highlight the different machine learning and deep learning (DL) techniques of different models used for the detection, classification, and prediction of cancerous lung tumors. The efficient model of Tiny DL must be built to assist physicians who are working in rural medical centers for swift and rapid diagnosis of lung cancer. The combination of lightweight Convolutional Neural Networks and limited resources could produce a portable model with low computational cost that has the ability to substitute the skill and experience of doctors needed in urgent cases.
Artificial intelligence (AI) is rapidly advancing as a valuable tool in oncology for enhancing detection and management of cancer. The integration of AI with PET/CT imaging presents significant scenarios for improving efficiency and accuracy of cancer diagnosis. This study examines the current applications of AI with PET/CT imaging, highlighting its role in diagnosing, differentiating, delineating, staging, assessing therapy response, determining prognosis, and enhancing image quality. A comprehensive literature search was conducted in six data-bases to get the most recent works, use Springer, Scopus, PubMed, Web of Science, IEEE, and Google Scholar in the last five years (2019-2024), identifying 80 studies that met the criteria for inclusion that focused on AI-driven models applied to PET/CT data in various cancers, with lung cancer being the most studied. Other cancers examined include head and neck, breast, lymph nodes, whole body, and others. All studies involved human subjects. The findings indicate that AI holds promise in improving cancer detection, identifying benign from malignant tumors, aiding in segmentation, response evaluation, staging, and determining the prognosis. However, the application of AI-powered models and PET/CT-derived radiomics in clinical practice is limited because of issues of data normalization, reproducibility, and the requirement of large multi-center data sets for improving model generalizability. All these limitations have to be solved to guarantee the dependable and ethical use of AI in day-to-day clinical activities.
One of the most common causes of mortality worldwide is Lung cancer, an early diagnosis crucial for a patient’s survival and recovery. Automated segmentation of lung lesions in chest CT has become a pre-eminent focal point for research, particularly with the development of hybrid methods combining traditional image processing with advanced deep learning methods such as CNN. These hybrid approaches aim to minimize individual methods limitations by controlling their merge strengths to enhance segmentation efficiency, precision, and clinical utility. This review comprehensively analyzes different hybrid techniques, such as deep learning improved by rule-based systems, multi-scale feature extraction, and ensemble learning. As well as inspect their clinical effect, particularly in improving diagnostic accuracy and optimizing treatment procedures. Despite their possibility, these approaches still face significant challenges, such as computational complexity, data requirements, and the requirement for explainable AI (XAI). Upcoming advancements in lung lesion segmentation will focus on refining these models to achieve faster processing, improved accuracy, and integration with diagnostic tools to protect transparency and ethical considerations.